Biomarker testing is important to treat patients fighting cancer 

We are in an exciting age of “precision medicine” where increasingly sophisticated tests—including for biomarkers—guide increasingly effective treatments for patients fighting cancer. Now, this progress is threatened by proposals in Washington that would devastate the drug discovery pipeline. Will patients battling cancer, now and in the future, be denied access to promising drugs? Arizona’s own …